84-5014-86 NR1I3 (Nuclear Receptor Subfamily 1 Group I Member 3) 100ul 487173
特徴
- NR1I3 mediates the induction of transcription of cytochrome P450 (CYP) genes by phenobarbital (PB) and PB-type inducers.
- NR1I3 activation induces hepatic expression of detoxification enzymes and transporters and increases liver size.
- NR1I3 can also regulate both liver homeostasis and tumorigenesis in response to xenobiotic stresses.
- Applications:Suitable for use in Immunohistochemistry, Western Blot.
- Other applications not tested.
- Recommended Dilution:Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size：100ul
- Host：rabbit
- Source Antibody：human
- Grade：Affinity Purified
- Purity：Purified by Protein A affinity chromatography.
- Form：Supplied as a liquid in PBS, 2% sucrose, 0.09% sodium azide.
- Specificity：Recognizes human NR1I3.
- Isotype：IgG
- Calc Applications Abbrev：IHC WB
- Calc Crossreactivity：Hu
- Immunogen：Synthetic peptide corresponding to the N-terminal region of human NR1I3
- Shelf Life：1year
- Swiss Prot Number：Q5VTW5
- EU Commodity Code：30021010
- この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
